CRISPR Therapeutics AG

SecurityCRSP / CRISPR Therapeutics AG
InstitutionSimplex Trading, Llc
Latest Disclosed Ownership1,407 shares
Latest Disclosed Value $ 66,930
Simplex Trading, Llc ownership in CRSP / CRISPR Therapeutics AG

On May 14, 2026 - Simplex Trading, Llc filed a 13F-HR form disclosing ownership of 1,407 shares of CRISPR Therapeutics AG (US:CRSP) valued at $66,931 USD as of March 31, 2026. The entity filed a previous 13F-HR on May 12, 2025 disclosing 0 shares of CRISPR Therapeutics AG. The current value of the position is $73,277 USD.

Simplex Trading, Llc has a history of taking positions in derivatives of the underlying security (CRSP) in the form of stock options. The firm currently holds call options representing 63,400 of underlying shares valued at $3,015,938 USD and put options representing 76,300 of underlying shares valued at $3,629,591 USD .

Note: prior versions of this page mistakenly stated that the share values represented the number of options, not the number of underlying shares. For more information on the data backing these reports, please see the SEC document Frequently Asked Questions About Form 13F.

Institutional Ownership: 13F and NPORT Filings

The Security and Class in the table below are shown exactly as filed by the investor. We do our best to track continuity of investments through acquisitions, and this will be reflected in the table as changes in names. In addition to descriptive data, performance of the investment is shown over time. To calculate quarterly performance, we first calculate cost basis of the shares purchased during the quarter, then use that to calculate gross profit. Quarterly return is Gross Profit / Starting Portfolio value.

Note that cost basis is calculated and stored in thousands, so small quarterly changes in shares frequently result in a cost basis of zero.

Upgrade to unlock premium data and export to Excel .

Institutional Put/Call Ratios
(Premium Subscription Required)

In addition to reporting standard equity and debt issues, institutions with more than 100MM assets under management must also disclose their put and call option holdings. Since put options generally indicate negative sentiment, and call options indicate positive sentiment, we can get a sense of the overall institutional sentiment by plotting the ratio of puts to calls. The chart to the right plots the historical put/call ratio for this instrument.

Using Put/Call Ratio as an indicator of investor sentiment overcomes one of the key deficiencies of using total institutional ownership, which is that a significant amount of assets under management are invested passively to track indices. Passively-managed funds do not typically buy options, so the put/call ratio indicator more closely tracks the sentiment of actively-managed funds.

CRSP / CRISPR Therapeutics AG Historical Put/Call Ratio
Disclosed Equity Positions (from 13F/NPORT Filings)
File
Date
Effective
Date
Form Security Class ID Avg Price
Paid (Est)
Reported
Shares
ΔShares ΔShares
(%)
Reported
Value
(x1000)
ΔValue
(%)
Alloc
(%)
ΔAlloc ΔAlloc (%) Cost Basis
(x1000)
Unrealized
Gain/Loss
(x1000)
2026-05-14 2026-03-31 13F CRISPR THERAPEUTICS COM H17182108 1,407 1,407 67 0.0000
2025-05-12 2025-03-31 13F CRISPR THERAPEUTICS COM H17182108 0 -83,134 -100.00 0 -100.00
2025-02-11 2024-12-31 13F CRISPR THERAPEUTICS COM H17182108 83,134 16,254 24.30 3 0.00 0.0018
2024-11-08 2024-09-30 13F CRISPR THERAPEUTICS COM H17182108 66,880 66,880 3 0.0018
2024-02-02 2023-12-31 13F CRISPR THERAPEUTICS COM H17182108 0 -34,794 -100.00 0 -100.00
2023-11-01 2023-09-30 13F CRISPR THERAPEUTICS COM H17182108 34,794 32,454 1,386.92 2 0.0012
2023-08-04 2023-06-30 13F CRISPR THERAPEUTICS COM H17182108 2,340 -13,437 -85.17 0 0.0001
2023-04-27 2023-03-31 13F CRISPR THERAPEUTICS COM H17182108 15,777 9,919 169.32 1 0.0006
2023-02-02 2022-12-31 13F CRISPR THERAPEUTICS COM H17182108 5,858 3,518 150.34 0 -100.00 0.0003
2022-11-04 2022-09-30 13F CRISPR THERAPEUTICS COM H17182108 2,340 0 0.00 152 7.04 0.0002
2022-08-03 2022-06-30 13F CRISPR THERAPEUTICS COM H17182108 2,340 -14,298 -85.94 142 -86.40 0.0002
2022-05-02 2022-03-31 13F CRISPR THERAPEUTICS COM H17182108 16,638 3,217 23.97 1,044 2.65 0.0010
2022-02-23 2021-12-31 13F/A-1 CRISPR THERAPEUTICS COM H17182108 13,421 -1,765 -11.62 1,017 -57.23 0.0010
2022-02-04 2021-12-31 13F CRISPR THERAPEUTICS COM H17182108 15,186 0 2,378 0.0022
2021-10-28 2021-09-30 13F CRISPR THERAPEUTICS COM H17182108 15,186 412 2.79 2,378 -0.54 0.0022
2021-08-12 2021-06-30 13F CRISPR THERAPEUTICS COM H17182108 14,774 12,794 646.16 2,391 892.12 0.0023
2021-04-26 2021-03-31 13F CRISPR THERAPEUTICS COM H17182108 1,980 -11,953 -85.79 241 -88.70 0.0004
2021-02-02 2020-12-31 13F CRISPR THERAPEUTICS COM H17182108 13,933 13,933 603.69 2,133 785.06 0.0028
2020-10-14 2020-09-30 13F CRISPR THERAPEUTICS COM H17182108 0 -5,082 -100.00 0 -100.00
2020-07-13 2020-06-30 13F CRISPR THERAPEUTICS COM H17182108 5,082 4,991 5,484.62 373 12,333.33 0.0006
2020-04-29 2020-03-31 13F CRISPR THERAPEUTICS COM H17182108 91 91 -98.21 3 -99.20 0.0000
2018-07-30 2018-06-30 13F CRISPR THERAPEUTICS COM H17182108 0 -20,015 -100.00 0 -100.00
2018-04-26 2018-03-31 13F CRISPR THERAPEUTICS COM H17182108 20,015 17,247 623.09 914 1,328.13 0.0402
2018-01-10 2017-12-31 13F CRISPR THERAPEUTICS COM H17182108 2,768 -555 -16.70 64 8.47 0.0028
2017-10-25 2017-09-30 13F CRISPR THERAPEUTICS COM H17182108 3,323 3,323 59 0.0024
Disclosed Call Options
File
Date
Effective
Date
Form Security Class ID Opt Avg Share
Price
Shares ΔShares
(%)
Value
(x1000)
ΔValue
(%)
Prior Allocation
(%)
Allocation
(%)
ΔAllocation
(%)
Cost Basis
(x1000)
Profit
(x1000)
Return
(%)
2026-05-14 2026-03-31 13F CRISPR THERAPEUTICS CALL Call 63,400 -65.01 3,016 -68.27 n/a n/a n/a
2026-02-11 2025-12-31 13F CRISPR THERAPEUTICS CALL Call 181,200 -12.08 9,502 72,992.31 n/a n/a n/a
2025-11-12 2025-09-30 13F CRISPR THERAPEUTICS CALL Call 206,100 4.20 13 44.44 n/a n/a n/a
2025-08-05 2025-06-30 13F CRISPR THERAPEUTICS CALL Call 197,800 -8.26 10 28.57 n/a n/a n/a
2025-05-12 2025-03-31 13F CRISPR THERAPEUTICS CALL Call 215,600 47.67 7 40.00 n/a n/a n/a
2025-02-11 2024-12-31 13F CRISPR THERAPEUTICS CALL Call 146,000 -0.88 6 -16.67 n/a n/a n/a
2024-11-08 2024-09-30 13F CRISPR THERAPEUTICS CALL Call 147,300 -22.84 7 -40.00 n/a n/a n/a
2024-07-25 2024-06-30 13F CRISPR THERAPEUTICS CALL Call 190,900 -37.22 10 -50.00 n/a n/a n/a
2024-04-25 2024-03-31 13F CRISPR THERAPEUTICS CALL Call 304,100 21.64 21 33.33 n/a n/a n/a
2024-02-02 2023-12-31 13F CRISPR THERAPEUTICS CALL Call 250,000 200.48 16 400.00 n/a n/a n/a
2023-11-01 2023-09-30 13F CRISPR THERAPEUTICS CALL Call 83,200 -45.12 4 -62.50 n/a n/a n/a
2023-08-04 2023-06-30 13F CRISPR THERAPEUTICS CALL Call 151,600 69.96 9 100.00 n/a n/a n/a
2023-04-27 2023-03-31 13F CRISPR THERAPEUTICS CALL Call 89,200 -49.92 4 -42.86 n/a n/a n/a
2023-02-02 2022-12-31 13F CRISPR THERAPEUTICS CALL Call 178,100 61.47 7 -99.90 n/a n/a n/a
2022-11-04 2022-09-30 13F CRISPR THERAPEUTICS CALL Call 110,300 -12.88 7,208 -6.30 n/a n/a n/a
2022-08-03 2022-06-30 13F CRISPR THERAPEUTICS CALL Call 126,600 74.62 7,693 69.08 n/a n/a n/a
2022-05-02 2022-03-31 13F CRISPR THERAPEUTICS CALL Call 72,500 -57.40 4,550 -64.72 n/a n/a n/a
2022-02-23 2021-12-31 13F/A CRISPR THERAPEUTICS CALL Call 170,200 96.08 12,897 -5.14 n/a n/a n/a
2022-02-04 2021-12-31 13F CRISPR THERAPEUTICS CALL Call 86,800 13,596 n/a n/a n/a
2021-10-28 2021-09-30 13F CRISPR THERAPEUTICS CALL Call 86,800 2.48 13,596 -0.85 n/a n/a n/a
2021-08-12 2021-06-30 13F CRISPR THERAPEUTICS CALL Call 84,700 9,794.86 13,712 31.47 n/a n/a n/a
2021-04-26 2021-03-31 13F CRISPR THERAPEUTICS CALL Call 856 -8.45 10,430 -27.14 n/a n/a n/a
2021-02-02 2020-12-31 13F CRISPR THERAPEUTICS CALL Call 935 171.80 14,315 397.57 n/a n/a n/a
2020-10-14 2020-09-30 13F CRISPR THERAPEUTICS CALL Call 344 -31.61 2,877 -22.16 n/a n/a n/a
2020-07-13 2020-06-30 13F CRISPR THERAPEUTICS CALL Call 503 58.18 3,696 174.18 n/a n/a n/a
2020-04-29 2020-03-31 13F CRISPR THERAPEUTICS CALL Call 318 3.25 1,348 -28.11 n/a n/a n/a
2020-02-05 2019-12-31 13F CRISPR THERAPEUTICS CALL Call 308 7.32 1,875 59.44 n/a n/a n/a
2019-10-15 2019-09-30 13F CRISPR THERAPEUTICS CALL Call 287 -39.32 1,176 -47.19 n/a n/a n/a
2019-07-26 2019-06-30 13F CRISPR THERAPEUTICS CALL Call 473 11.29 2,227 46.71 n/a n/a n/a
2019-04-18 2019-03-31 13F CRISPR THERAPEUTICS CALL Call 425 43.58 1,518 79.64 n/a n/a n/a
2019-01-16 2018-12-31 13F CRISPR THERAPEUTICS CALL Call 296 279.49 845 144.93 n/a n/a n/a
2018-10-23 2018-09-30 13F CRISPR THERAPEUTICS CALL Call 78 129.41 345 73.37 n/a n/a n/a
2018-07-30 2018-06-30 13F CRISPR THERAPEUTICS CALL Call 34 54.55 199 352.27 n/a n/a n/a
2018-04-26 2018-03-31 13F CRISPR THERAPEUTICS CALL Call 22 100.00 44 300.00 n/a n/a n/a
2018-01-10 2017-12-31 13F CRISPR THERAPEUTICS CALL Call 11 266.67 11 -75.00 n/a n/a n/a
2017-10-25 2017-09-30 13F CRISPR THERAPEUTICS CALL Call 3 -85.00 0 -100.00 n/a n/a n/a
2017-07-12 2017-06-30 13F CRISPR THERAPEUTICS CALL Call 20 1 n/a n/a n/a
Disclosed Put Options
File
Date
Effective
Date
Form Security Class ID Opt Avg Share Price Shares ΔShares
(%)
Value
(x1000)
ΔValue
(%)
Prior Allocation
(%)
Allocation
(%)
ΔAllocation
(%)
Cost Basis
(x1000)
Profit
(x1000)
Return
(%)
2026-05-14 2026-03-31 13F CRISPR THERAPEUTICS PUT Put 76,300 -46.00 3,630 -51.02 n/a n/a n/a
2026-02-11 2025-12-31 13F CRISPR THERAPEUTICS PUT Put 141,300 -8.19 7,410 82,222.22 n/a n/a n/a
2025-11-12 2025-09-30 13F CRISPR THERAPEUTICS PUT Put 153,900 56.56 10 125.00 n/a n/a n/a
2025-08-05 2025-06-30 13F CRISPR THERAPEUTICS PUT Put 98,300 37.87 5 100.00 n/a n/a n/a
2025-05-12 2025-03-31 13F CRISPR THERAPEUTICS PUT Put 71,300 -43.73 2 -50.00 n/a n/a n/a
2025-02-11 2024-12-31 13F CRISPR THERAPEUTICS PUT Put 126,700 14.35 5 -20.00 n/a n/a n/a
2024-11-08 2024-09-30 13F CRISPR THERAPEUTICS PUT Put 110,800 -26.13 5 -37.50 n/a n/a n/a
2024-07-25 2024-06-30 13F CRISPR THERAPEUTICS PUT Put 150,000 -34.30 8 -46.67 n/a n/a n/a
2024-04-25 2024-03-31 13F CRISPR THERAPEUTICS PUT Put 228,300 23.94 16 36.36 n/a n/a n/a
2024-02-02 2023-12-31 13F CRISPR THERAPEUTICS PUT Put 184,200 40.61 12 120.00 n/a n/a n/a
2023-11-01 2023-09-30 13F CRISPR THERAPEUTICS PUT Put 131,000 49.89 6 25.00 n/a n/a n/a
2023-08-04 2023-06-30 13F CRISPR THERAPEUTICS PUT Put 87,400 18.91 5 33.33 n/a n/a n/a
2023-04-27 2023-03-31 13F CRISPR THERAPEUTICS PUT Put 73,500 -3.03 3 0.00 n/a n/a n/a
2023-02-02 2022-12-31 13F CRISPR THERAPEUTICS PUT Put 75,800 170.71 3 -99.84 n/a n/a n/a
2022-11-04 2022-09-30 13F CRISPR THERAPEUTICS PUT Put 28,000 -52.14 1,829 -48.55 n/a n/a n/a
2022-08-03 2022-06-30 13F CRISPR THERAPEUTICS PUT Put 58,500 -20.41 3,555 -22.94 n/a n/a n/a
2022-05-02 2022-03-31 13F CRISPR THERAPEUTICS PUT Put 73,500 -0.94 4,613 -17.95 n/a n/a n/a
2022-02-23 2021-12-31 13F/A CRISPR THERAPEUTICS PUT Put 74,200 -1.59 5,622 -52.40 n/a n/a n/a
2022-02-04 2021-12-31 13F CRISPR THERAPEUTICS PUT Put 75,400 11,810 n/a n/a n/a
2021-10-28 2021-09-30 13F CRISPR THERAPEUTICS PUT Put 75,400 3.01 11,810 -0.34 n/a n/a n/a
2021-08-12 2021-06-30 13F CRISPR THERAPEUTICS PUT Put 73,200 24,713.56 11,850 229.72 n/a n/a n/a
2021-04-26 2021-03-31 13F CRISPR THERAPEUTICS PUT Put 295 -28.57 3,594 -43.16 n/a n/a n/a
2021-02-02 2020-12-31 13F CRISPR THERAPEUTICS PUT Put 413 16.67 6,323 113.61 n/a n/a n/a
2020-10-14 2020-09-30 13F CRISPR THERAPEUTICS PUT Put 354 -27.61 2,960 -17.62 n/a n/a n/a
2020-07-13 2020-06-30 13F CRISPR THERAPEUTICS PUT Put 489 9.15 3,593 89.20 n/a n/a n/a
2020-04-29 2020-03-31 13F CRISPR THERAPEUTICS PUT Put 448 17.28 1,899 -18.36 n/a n/a n/a
2020-02-05 2019-12-31 13F CRISPR THERAPEUTICS PUT Put 382 40.96 2,326 109.55 n/a n/a n/a
2019-10-15 2019-09-30 13F CRISPR THERAPEUTICS PUT Put 271 -2.52 1,110 -15.20 n/a n/a n/a
2019-07-26 2019-06-30 13F CRISPR THERAPEUTICS PUT Put 278 60.69 1,309 112.16 n/a n/a n/a
2019-04-18 2019-03-31 13F CRISPR THERAPEUTICS PUT Put 173 162.12 617 228.19 n/a n/a n/a
2019-01-16 2018-12-31 13F CRISPR THERAPEUTICS PUT Put 66 24.53 188 -20.00 n/a n/a n/a
2018-10-23 2018-09-30 13F CRISPR THERAPEUTICS PUT Put 53 -69.89 235 -77.27 n/a n/a n/a
2018-07-30 2018-06-30 13F CRISPR THERAPEUTICS PUT Put 176 -59.45 1,034 363.68 n/a n/a n/a
2018-04-26 2018-03-31 13F CRISPR THERAPEUTICS PUT Put 434 1,346.67 223 1,492.86 n/a n/a n/a
2018-01-10 2017-12-31 13F CRISPR THERAPEUTICS PUT Put 30 -43.40 14 -48.15 n/a n/a n/a
2017-10-25 2017-09-30 13F CRISPR THERAPEUTICS PUT Put 53 27 n/a n/a n/a
Legend
Shares
The total number of shares held by the institution at the end of the reporting period (the effective date). This is provided in the filing.
Value
The total value of the shares as of the effective date. This is provided in the filing.
Avg. Share Price
The weighted average share price of the shares held by the institution. We use FIFO accounting to determine this price
Class
This is the security class as indicated by the filer. There are a variety of values for this field. Common values include "EC" = equity common, "EP" - equity preferred
Allocation (%)
The percent of the institution's portfolio that this position represents. This is provided in NPORT filings. For 13F filings, we calculate it.
Change in Allocation
The change in allocation from the prior reporting period. This is calculated as current allocation - prior allocation.
Change in Allocation (%)
The percent change in allocation from the prior reporting period. This is calculated as (current allocation - prior allocation) / prior allocation.
Cost Basis
The total cost of the shares held. This is calculated as reported shares * avg. share price
Unrealized Gain/Loss
This is the market value of the position as of the effective date minus the cost basis.